DUNCAN BARBARA GAYLE
SEC CIK 1353128 · EDGAR
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Atea Pharmaceuticals, Inc. | DUNCAN BARBARA GAYLE | Dir | M - OptEx | $0.00 | +29.6K | 92.3K | +47% | $0 |
| D | 2026-05-07 19:02 | 2026-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | DUNCAN BARBARA GAYLE | Dir | A - Grant | $0.00 | +3,796 | 23.7K | +19% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Atea Pharmaceuticals, Inc. | Duncan Barbara Gayle | Dir | M - OptEx | $0.00 | +29.6K | 62.8K | +89% | $0 |
| D | 2025-05-02 | 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | Duncan Barbara Gayle | Dir | A - Grant | $0.00 | +4,165 | 19.9K | +26% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Atea Pharmaceuticals, Inc. | Duncan Barbara Gayle | Dir | M - OptEx | $0.00 | +33.1K | 33.1K | New | $0 |
| D | 2024-04-29 | 2024-04-25 | HALO | HALOZYME THERAPEUTICS, INC. | Duncan Barbara Gayle | Dir | A - Grant | $0.00 | +6,501 | 15.8K | +70% | $0 |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Duncan Barbara Gayle | Dir | A - Grant | $0.00 | +8,065 | 9,253 | +679% | $0 |
| 2023-02-07 | 2023-02-03 | HALO | HALOZYME THERAPEUTICS, INC. | Duncan Barbara Gayle | Dir | A - Grant | $0.00 | +1,188 | 1,188 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations